Are anti-EGFR monoclonal antibodies the magic bullets that remove circulating tumor cells in patients with non-small cell lung cancer (NSCLC)?

Prize

Description

(€175.000).
Degree of recognitionNational
Granting OrganisationsKoningin Wilhelmina Fonds (KWF)